Overview
Status
Active
Registry date
2012-05-28
Share capital
5,000.00 PLN
Registered address
al. Mickiewicza 21, 31-120 Kraków, Poland
Financials
Total Operating Costs
0.00
–
Revenue history
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 94 days for 2021).
- 202526/09/2026
- 202426/09/2025
- 202326/09/2024
- 202225/09/2023
- 202117/10/2022
- 202027/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 75.34MedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -2.51MedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 0.00MedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 1.28kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Janusz Marek Strzępek – President of the Management Board
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly are authorized to make declarations of will on behalf of the company and to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marek Jan Cioskage 63 | 50 | $675.31 | 50% |
Janusz Marek Strzępekage 58 | 50 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company SMC Pharma.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Change history
| Date | Event | |
|---|---|---|
| 2021-02-22 | PKD change (Removed: 31 codes) | |
| 2012-05-28 | Entered in the register |
FAQ
Last updated: 2026-09-26